Gene-Edited Stem Cells in Cardiomyopathy and Heart Failure Therapy
تقنيات تحرير الجينات, notably CRISPR-Cas9, offer unprecedented opportunities to rectify genetic defects in cardiomyocytes, potentially revolutionizing cardiomyopathy and heart failure therapy. This article explores the state-of-the-art applications of gene-edited stem cells, highlighting their therapeutic potential and challenges in clinical translation.